The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
The most common is hypothyroidism
The same applies if you are switching between GLP-1 medications
Berberine combined with semaglutide (or liraglutide) has attracted interest for additional metabolic benefits, though timing of supplementation matters due to absorption effects
Tirzepatide, also known as Zepbound, might be the solution youve been waiting for
Understanding which medication carries which risk profile allows you to take targeted prevention measures rather than worrying about risks that do not actually apply to your semaglutide protocol